Literature DB >> 11237812

Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.

M J Linke1, C E Harris, T R Korfhagen, F X McCormack, A D Ashbaugh, P Steele, J A Whitsett, P D Walzer.   

Abstract

Immunosuppressed Swiss Black mice deficient in surfactant protein A (SP-A(-/-)) and wild-type control mice (SP-A(+/+)) were exposed to Pneumocystis carinii by environmental exposure, intratracheal inoculation, and direct exposure to other infected animals. The frequency and intensity of P. carinii infection were significantly greater in the SP-A(-/-) mice by all 3 methods of exposure. P. carinii free of SP-A and alveolar macrophages were isolated from SP-A(-/-) mice and were tested in an in vitro attachment assay. Pretreatment of P. carinii with human SP-A resulted in a significant dose-dependent increase of the adherence of P. carinii to the macrophages. Thus, SP-A plays a role in host defense against P. carinii in vivo, perhaps by functioning as a nonimmune opsonin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237812     DOI: 10.1086/319252

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung.

Authors:  Francis X McCormack; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Identification of the surfactant protein A receptor 210 as the unconventional myosin 18A.

Authors:  Ching-Hui Yang; Jacek Szeliga; Jeremy Jordan; Shawn Faske; Zvjezdana Sever-Chroneos; Bre Dorsett; Robert E Christian; Robert E Settlage; Jeffrey Shabanowitz; Donald F Hunt; Jeffrey A Whitsett; Zissis C Chroneos
Journal:  J Biol Chem       Date:  2005-08-08       Impact factor: 5.157

3.  Lung infections and innate host defense.

Authors:  Ma Valdivia-Arenas; A Amer; Ln Henning; Md Wewers; Ls Schlesinger
Journal:  Drug Discov Today Dis Mech       Date:  2007

4.  Mature Surfactant Protein-B Expression by Immunohistochemistry as a Marker for Surfactant System Development in the Fetal Sheep Lung.

Authors:  Mitchell C Lock; Erin V McGillick; Sandra Orgeig; Song Zhang; I Caroline McMillen; Janna L Morrison
Journal:  J Histochem Cytochem       Date:  2015-08-21       Impact factor: 2.479

5.  New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies.

Authors:  Timothy D Thullen; Alan D Ashbaugh; Kieran R Daly; Michael J Linke; Paul E Steele; Peter D Walzer
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

6.  Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice.

Authors:  Michael J Linke; Alan A Ashbaugh; Judith V Koch; Linda Levin; Reiko Tanaka; Peter D Walzer
Journal:  J Eukaryot Microbiol       Date:  2009 Jan-Feb       Impact factor: 3.346

7.  Pulmonary effects of inhaled diesel exhaust in aged mice.

Authors:  Vasanthi R Sunil; Kinal J Patel; Gediminas Mainelis; Barbara J Turpin; Sherritta Ridgely; Robert J Laumbach; Howard M Kipen; Yevgen Nazarenko; Manoj Veleeparambil; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2009-09-01       Impact factor: 4.219

8.  Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation.

Authors:  Angela Haczku
Journal:  J Allergy Clin Immunol       Date:  2008-11       Impact factor: 10.793

9.  CRISPRi-mediated functional analysis of NKX2-1-binding sites in the lung.

Authors:  William D Stuart; Iris M Fink-Baldauf; Koichi Tomoshige; Minzhe Guo; Yutaka Maeda
Journal:  Commun Biol       Date:  2021-05-12

10.  Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.

Authors:  Elena N Atochina; James M Beck; Angela M Preston; Angela Haczku; Yaniv Tomer; Seth T Scanlon; Trevor Fusaro; John Casey; Samuel Hawgood; Andrew J Gow; Michael F Beers
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.